Knight Therapeutics

Overview

• HeadquartersWestmount¹
• Websitegud-knight.com/en
• Legal formINCORPORATED / INCORPOREE⁴
• LEI549300GUGCJS5XAALN35⁴
• StatusInactive⁴
• LEI statusRetired⁴
• Registered address376 Victoria Avenue, H3Z 1C3 Westmount, Canada⁴
• Registered withCorporations Canada, 868054-0⁴

See how the biggest companies compare on our leaderboards

Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets.³

Corporate structure

Knight Therapeutics sits at the top of its group. 3 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Stakes it holds

Knight Therapeutics has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

• 60 DEGREES PHARMACEUTICALS, INC.SCHEDULE 13G Nov 13, 2024 to Jul 29, 2026⁵
• Synergy CHC Corp.SCHEDULE 13G/A Mar 20, 2025 to Jun 13, 2025⁶

SEC filer profile

How Knight Therapeutics is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARKnight Therapeutics Inc.²
• CIK0001756235
• LEI549300LNW93V3HRS7610²
• Incorporated inQuebec, Canada²
• Fiscal year endsDecember 31²
• Business address600-100 Boul. Alexis-Nihon, Montreal, H4M2P2, Quebec, Canada²
• Phone5144844483²
• On EDGAR sinceOct 17, 2018²
• Filings12 in all: 3 (3), 4 (2), SC 13G/A (2), SCHEDULE 13G (2), SCHEDULE 13G/A (2), SC 13G (1)²

Links

• Websitegud-knight.com/en¹
• WikipediaKnight Therapeutics
• WikidataQ48743359
• SEC EDGARCIK 1756235